StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report released on Wednesday morning. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens raised their price objective on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
View Our Latest Stock Report on Veradigm
Veradigm Trading Down 7.0 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Why Are Stock Sectors Important to Successful Investing?
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
